Compare $CVM vs $NNVC | Chartloom

Compare

$CVM vs $NNVC

CEL-SCI Corp · NanoViricides, Inc

CVM

CEL-SCI Corp

NNVC

NanoViricides, Inc

Compare $CVM vs $NNVC

Comparing CEL-SCI Corp and NanoViricides, Inc

CVMCEL-SCI Corp

NNVCNanoViricides, Inc

CVMCEL-SCI Corp

Market cap

$34M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-62.3%

52W performance

-80.7%

FCF yield

-49.4%

NNVCNanoViricides, Inc

Market cap

$33M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

7.4%

52W performance

-9.1%

FCF yield

-23.6%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CVM

NNVC

Detailed metrics comparison

CVM

CEL-SCI Corp

NNVC

NanoViricides, Inc

Market Cap

CVM$34M

NNVC$33M

Enterprise Value

CVM$34M

NNVC$30M

Price

CVM$1.94

NNVC$1.30

P/E Ratio

CVMN/A

NNVCN/A

P/S Ratio

CVM72.73x

NNVC0.00x

EV/Sales

CVM72.27x

NNVC0.00x

EV/EBITDA

CVM0.00x

NNVC0.00x

P/B Ratio

CVM3.71x

NNVC3.76x

P/FCF Ratio

CVMN/A

NNVCN/A

EV/FCF

CVM-2.01x

NNVC-3.88x

PEG Ratio

CVMN/A

NNVCN/A

Forward P/E (NTM)

CVMN/A

NNVCN/A

Forward P/S (NTM)

CVMN/A

NNVCN/A

Revenue (TTM)

CVM$0

NNVC$0

Revenue Growth (YoY)

CVMN/A

NNVCN/A

Forward Rev Growth

CVM0.0%

NNVC0.0%

Gross Margin (TTM)

CVM0.0%

NNVC0.0%

Operating Margin (TTM)

CVM0.0%

NNVC0.0%

EBITDA Margin (TTM)

CVM0.0%

NNVC0.0%

Net Margin (TTM)

CVM0.0%

NNVC0.0%

FCF Margin (TTM)

CVMN/A

NNVCN/A

Net Income (TTM)

CVM$-23M

NNVC$-8M

FCF (TTM)

CVM$-17M

NNVC$-8M

EPS (TTM)

CVM-$1.87

NNVC-$0.37

ROE (TTM)

CVM-20214.0%

NNVC-9111.0%

ROA (TTM)

CVM-10078.0%

NNVC-8074.0%

ROIC (TTM)

CVM-12370.0%

NNVC-9111.0%

Cash

CVM$7M

NNVC$3M

Debt

CVM$6M

NNVC$0

Net Cash/Debt

CVM$256K

NNVC$3M

Current Ratio (TTM)

CVM1.48x

NNVC2.66x

Quick Ratio (TTM)

CVM1.29x

NNVC2.35x

Debt/Equity (TTM)

CVM0.57x

NNVC0.00x

Debt/Assets (TTM)

CVM0.0%

NNVC0.0%

Interest Coverage (TTM)

CVMN/A

NNVCN/A

Net Debt/EBITDA (TTM)

CVM0.00x

NNVC0.00x

Beta

CVM0.62

NNVC1.91

52W Performance

CVM-80.7%

NNVC-9.1%

YTD Performance

CVM-62.3%

NNVC7.4%

% from 52W High

CVM-81.3%

NNVC-41.7%

% from 52W Low

CVM118.0%

NNVC52.9%

Asset Turnover (TTM)

CVM0.01x

NNVC0.00x

FCF Yield (TTM)

CVM-49.4%

NNVC-23.6%

Earnings Yield (TTM)

CVM-67.0%

NNVC-24.9%

Dividend Yield (TTM)

CVMN/A

NNVCN/A

Rule of 40

CVM0.0

NNVC0.0

EV/GP/RG

CVMN/A

NNVCN/A

Ticker research

View CVM research View NNVC research

Metric	CVM CEL-SCI Corp	NNVC NanoViricides, Inc
Market & Valuation
Market Cap	$34M	$33M
Enterprise Value	$34M	$30M
Price	$1.94	$1.30
P/E Ratio	N/A	N/A
P/S Ratio	72.73x	0.00x
EV/Sales	72.27x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	3.71x	3.76x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.01x	-3.88x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-23M	$-8M
FCF (TTM)	$-17M	$-8M
EPS (TTM)	-$1.87	-$0.37
ROE (TTM)	-20214.0%	-9111.0%
ROA (TTM)	-10078.0%	-8074.0%
ROIC (TTM)	-12370.0%	-9111.0%
Financial Health
Cash	$7M	$3M
Debt	$6M	$0
Net Cash/Debt	$256K	$3M
Current Ratio (TTM)	1.48x	2.66x
Quick Ratio (TTM)	1.29x	2.35x
Debt/Equity (TTM)	0.57x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.62	1.91
52W Performance	-80.7%	-9.1%
YTD Performance	-62.3%	7.4%
% from 52W High	-81.3%	-41.7%
% from 52W Low	118.0%	52.9%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.00x
FCF Yield (TTM)	-49.4%	-23.6%
Earnings Yield (TTM)	-67.0%	-24.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View CVM research	View NNVC research

Valuation

P/S Ratio

NNVC

0.00x

CVM

72.73x

EV/FCF

NNVC

-3.88x

CVM

-2.01x

Growth & revenue

Forward Revenue Growth

CVM

0.0%

NNVC

0.0%

Profitability & performance

Gross Margin

CVM

0.0%

NNVC

0.0%

ROE

NNVC

-9111.0%

CVM

-20214.0%

FCF Yield %

NNVC

-23.6%

CVM

-49.4%

52-Week Performance

NNVC

-9.1%

CVM

-80.7%

Detailed metrics comparison

CVM

CEL-SCI Corp

NNVC

NanoViricides, Inc

Market Cap

CVM$34M

NNVC$33M

Enterprise Value

CVM$34M

NNVC$30M

Price

CVM$1.94

NNVC$1.30

P/E Ratio

CVMN/A

NNVCN/A

P/S Ratio

CVM72.73x

NNVC0.00x

EV/Sales

CVM72.27x

NNVC0.00x

EV/EBITDA

CVM0.00x

NNVC0.00x

P/B Ratio

CVM3.71x

NNVC3.76x

P/FCF Ratio

CVMN/A

NNVCN/A

EV/FCF

CVM-2.01x

NNVC-3.88x

PEG Ratio

CVMN/A

NNVCN/A

Forward P/E (NTM)

CVMN/A

NNVCN/A

Forward P/S (NTM)

CVMN/A

NNVCN/A

Revenue (TTM)

CVM$0

NNVC$0

Revenue Growth (YoY)

CVMN/A

NNVCN/A

Forward Rev Growth

CVM0.0%

NNVC0.0%

Gross Margin (TTM)

CVM0.0%

NNVC0.0%

Operating Margin (TTM)

CVM0.0%

NNVC0.0%

EBITDA Margin (TTM)

CVM0.0%

NNVC0.0%

Net Margin (TTM)

CVM0.0%

NNVC0.0%

FCF Margin (TTM)

CVMN/A

NNVCN/A

Net Income (TTM)

CVM$-23M

NNVC$-8M

FCF (TTM)

CVM$-17M

NNVC$-8M

EPS (TTM)

CVM-$1.87

NNVC-$0.37

ROE (TTM)

CVM-20214.0%

NNVC-9111.0%

ROA (TTM)

CVM-10078.0%

NNVC-8074.0%

ROIC (TTM)

CVM-12370.0%

NNVC-9111.0%

Cash

CVM$7M

NNVC$3M

Debt

CVM$6M

NNVC$0

Net Cash/Debt

CVM$256K

NNVC$3M

Current Ratio (TTM)

CVM1.48x

NNVC2.66x

Quick Ratio (TTM)

CVM1.29x

NNVC2.35x

Debt/Equity (TTM)

CVM0.57x

NNVC0.00x

Debt/Assets (TTM)

CVM0.0%

NNVC0.0%

Interest Coverage (TTM)

CVMN/A

NNVCN/A

Net Debt/EBITDA (TTM)

CVM0.00x

NNVC0.00x

Beta

CVM0.62

NNVC1.91

52W Performance

CVM-80.7%

NNVC-9.1%

YTD Performance

CVM-62.3%

NNVC7.4%

% from 52W High

CVM-81.3%

NNVC-41.7%

% from 52W Low

CVM118.0%

NNVC52.9%

Asset Turnover (TTM)

CVM0.01x

NNVC0.00x

FCF Yield (TTM)

CVM-49.4%

NNVC-23.6%

Earnings Yield (TTM)

CVM-67.0%

NNVC-24.9%

Dividend Yield (TTM)

CVMN/A

NNVCN/A

Rule of 40

CVM0.0

NNVC0.0

EV/GP/RG

CVMN/A

NNVCN/A

Ticker research

View CVM research View NNVC research

Metric	CVM CEL-SCI Corp	NNVC NanoViricides, Inc
Market & Valuation
Market Cap	$34M	$33M
Enterprise Value	$34M	$30M
Price	$1.94	$1.30
P/E Ratio	N/A	N/A
P/S Ratio	72.73x	0.00x
EV/Sales	72.27x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	3.71x	3.76x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.01x	-3.88x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-23M	$-8M
FCF (TTM)	$-17M	$-8M
EPS (TTM)	-$1.87	-$0.37
ROE (TTM)	-20214.0%	-9111.0%
ROA (TTM)	-10078.0%	-8074.0%
ROIC (TTM)	-12370.0%	-9111.0%
Financial Health
Cash	$7M	$3M
Debt	$6M	$0
Net Cash/Debt	$256K	$3M
Current Ratio (TTM)	1.48x	2.66x
Quick Ratio (TTM)	1.29x	2.35x
Debt/Equity (TTM)	0.57x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.62	1.91
52W Performance	-80.7%	-9.1%
YTD Performance	-62.3%	7.4%
% from 52W High	-81.3%	-41.7%
% from 52W Low	118.0%	52.9%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.00x
FCF Yield (TTM)	-49.4%	-23.6%
Earnings Yield (TTM)	-67.0%	-24.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View CVM research	View NNVC research